Jose Echegaray, MD
Retina Specialist · Altamonte Springs, FLNPI 1205275229
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,741 of the $5,370 with a category attached, or 69.7%. 22 manufacturers reported payments, led by Alimera Sciences, Inc. at 29.4% of the total.
Across 109 payments — averaging $49.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alimera Sciences, Inc.$2K
- Astellas Pharma US Inc$763
- Regeneron Healthcare Solutions, Inc.$419
- Regeneron$340
- AbbVie$328
- Novartis$326
- plus $2K from 16 others
What the payments were for
- Speaking & faculty fees$1,20022%
- Travel & lodging$3406%
- Food & beverage$3,74170%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alimera Sciences, Inc. | 15 | $1,580 |
| Astellas Pharma US Inc | 14 | $763 |
| Regeneron Healthcare Solutions, Inc. | 6 | $419 |
| Regeneron | 1 | $340 |
| AbbVie(2 entities) | 14 | $328 |
| Novartis | 7 | $326 |
| Apellis Pharmaceuticals, Inc. | 14 | $325 |
| Genentech USA, Inc. | 6 | $307 |
| Mallinckrodt Hospital Products Inc. | 7 | $184 |
| Harrow Eye, LLC | 5 | $141 |
| Immunocore Limited | 4 | $116 |
| Eyepoint US, Inc. | 2 | $107 |
| Alcon | 3 | $82 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Bausch & Lomb Americas Inc. | 1 | $69 |
| Halozyme Inc | 1 | $55 |
| ANI Pharmaceuticals, Inc. | 2 | $49 |
| Ocular Therapeutix, Inc. | 2 | $32 |
| Oyster Point Pharma, Inc. | 1 | $27 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Astellas Pharma Global Development | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,370 in reported general payments places this provider in the 55th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 71 | $4,653 |
| Ketorolac Tromethamine | 40 | $1,356 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 67 | $807 |
| Ofloxacin | 22 | $447 |
| Brimonidine Tartrate | 12 | $263 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $241 |
| Latanoprost | 30 | $183 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Altamonte Springs
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
- Timothy MurraySouth Miami$133K
- Adiel SmithAventura$116K
- Paul GalloglyPalm Beach Gardens$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.